Loading stock data…
ONMD
$1.00-0.08 (-7.85%)
Market ClosedLast close May 1
OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
OneMedNet Corporation in the Healthcare sector is trading at $1.00. The stock is currently near its 52-week low of $0.31, remaining 11.1% below its 200-day moving average. Technical signals show neutral RSI of 58 and bullish MACD crossover, explaining why ONMD maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 58) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.00
Potential Upside
5%
Whystock Fair Value$1.04
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. The company offers iRWD, which provides regulatory grade imaging and clinic...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$46.39M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.17
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
94.47%
Volume
Today's trading volume
752,911
Recent News
BC-Most Active Stocks
Elong Power Holding Ltd. 27,481,598 0.1358
Is Palantir (PLTR) One of the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies
Palantir Technologies, Inc. (NASDAQ:PLTR) is one of the best stocks to buy according to Jim Simons’ Renaissance Technologies. On October 6, OneMedNet Corporation announced a multi-year partnership with Palantir Technologies (NASDAQ;PLTR) to transform healthcare AI and Real-World Data (RWD) analytics. Palantir’s Artificial Intelligence Platform will power OneMedNet’s iRWD network, enabling life sciences and research organizations […]
Palantir Taps Healthcare AI Growth with OneMedNet Partnership
Palantir Technologies Inc. (NASDAQ:PLTR) is one of the fastest-growing AI stocks to invest in now. OneMedNet officially announced on October 6, 2025 that it had selected Palantir Technologies Inc. (NASDAQ:PLTR) to enhance its offerings in healthcare AI and real-world data analytics, linking its provider network with Palantir’s platform. The companies say the collaboration will integrate […]
Palantir Technologies (PLTR): Evaluating Valuation as Healthcare Deal Expands Its AI Platform’s Market Reach
Palantir Technologies is stepping up its healthcare ambitions through a new multi-year agreement with OneMedNet, bringing its Artificial Intelligence Platform to the forefront of transforming how clinical data is accessed and analyzed. This move expands Palantir's footprint well beyond its roots in government work and targets scalable, recurring revenue opportunities across healthcare and life sciences. See our latest analysis for Palantir Technologies. After an incredible run that saw its...
A Look at OneMedNet (ONMD) Valuation Following Strategic Medcase Collaboration in Healthcare AI Data
OneMedNet (ONMD) is making headlines after announcing a strategic partnership with Medcase, a global leader in medical data annotation. This collaboration brings OneMedNet into the expanding healthcare AI data market and offers recurring revenue potential alongside its core platform. See our latest analysis for OneMedNet. Following the news of its Medcase partnership, OneMedNet’s momentum has become hard to ignore. The shares have surged with a staggering 199% share price return over the past...